GALT - Galectin Therapeutics Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqCM). Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Get the latest Galectin Therapeutics Inc. Common Stock (GALT) real-time quote, historical performance, charts, and other financial information to help you. Get the latest updates on Galectin Therapeutics Inc. Common Stock (GALT) after hours trades, after hours share volumes, and more. Make informed investments. Galectin Therapeutics Inc. (NASDAQ:GALT) surges 16%; individual investors who own 59% shares profited along with insiders. Key Insights Significant control over.
View the real-time GALT price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Track Galectin Therapeutics Inc (GALT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Galectin Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today's real-time GALT stock price. Fundamentals · Market Capitalization, $K , · Shares Outstanding, K 62, · Annual Sales, $ 0 K · Annual Income, $ , K · Month Beta · Price/Sales. GALT Earnings Forecast. Next quarter's earnings estimate for GALT is -$ with a range of -$ to -$ The previous quarter's EPS was -$ GALT beat. Discover real-time Galectin Therapeutics Inc. Common Stock (GALT) stock prices, quotes, historical data, news, and Insights for informed trading and. Galectin Therapeutics Inc.'s stock symbol is GALT and currently trades under NASDAQ. It's current price per share is approximately $ GALT, Galectin Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin's lead drug (GR-MD, or belapectin) is a galectin-3 inhibitor. How to buy GALT stock on Public · Sign up for a brokerage account on Public · Add funds to your Public account · Choose how much you'd like to invest in GALT.
Analyst Forecast. According to one analyst, the rating for GALT stock is "Strong Buy" and the month stock price forecast is $ GALT | Complete Galectin Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin. Why Galectin Therapeutics (GALT) Stock Is Plummeting Today. Galectin Therapeutics (GALT) plummeted Tuesday after the company reported poor results in an early-. Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease. The latest Galectin Therapeutics stock prices, stock quotes, news, and GALT history to help you invest and trade smarter. (GALT) share was $ The week high for Galectin Therapeutics Inc. Stock is $ and the week low is $ View Galectin Therapeutics Inc. GALT stock quote prices, financial information, real-time forecasts, and company news from CNN. The current price of GALT is USD — it has increased by % in the past 24 hours. Watch Galectin Therapeutics Inc. stock price performance more closely on.
GALT does not currently pay a dividend. Shares. Market Capitalization (Micro Cap), $M. Shares Outstanding, M. Complete Galectin Therapeutics Inc. stock information by Barron's. View real-time GALT stock price and news, along with industry-best analysis. Get Galectin Therapeutics Inc (GALT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Determining whether Galectin Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to. Stock analysis for Galectin Therapeutics Inc (GALT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company.
Galectin Therapeutics Inc. stock grades by Barron's. View GALT fundamental and sentiment analysis powered by MarketGrader. Galectin Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. (NASDAQ: GALT) Galectin Therapeutics currently has 62,, outstanding shares. With Galectin Therapeutics stock trading at $ per share, the total value. Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile. Get Galectin Therapeutics Inc (GALT.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Webull offers Galectin Therapeutics Inc GALT historical stock prices, in-depth market analysis,NASDAQ:GALT real-time stock quote data, in-depth charts.
Cd Interest Rates Las Vegas | Bank Without Opening Deposit